FDA: Page 75
-
CMS wants to overhaul how organs are procured in the US
The agency estimates if all procurement groups met both the new donation and transplantation rate measures, the number of yearly transplants would shoot up more than 15% by 2026.
By Rebecca Pifer Parduhn • Dec. 17, 2019 -
Medical device, insurance and Cadillac taxes repealed in year-end spending bill draft
If enacted into the law as expected, it's a victory for AdvaMed in a years-long battle to scrap the 2.3% levy initially established to help fund coverage under the Affordable Care Act.
By David Lim • Dec. 17, 2019 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
EU Parliament finalizes 4-year MDR delay for some Class I devices
The delay will help slightly reduce the crush of products needing notified body review by May 26, 2020.
By David Lim • Updated Dec. 17, 2019 -
Tandem wins FDA go-ahead for 1st interoperable, automated insulin dosing software
The clearance of Tandem's Control-IQ algorithm is part of a broader regulatory vision for people with diabetes to have the freedom to pair their preferred glucose sensing and insulin delivery devices.
By Maria Rachal • Dec. 16, 2019 -
Boston Scientific gets 1st US disposable duodenoscope clearance
SVP of Endoscopy Art Butcher told investors last June the single-use duodenoscope could represent more than a $1 billion market opportunity.
By David Lim • Dec. 16, 2019 -
Hahn confirmed as next FDA commissioner in 72-18 Senate vote
Stephen Hahn's swift confirmation won applause from lawmakers, former FDA commissioners and industry groups.
By David Lim • Dec. 12, 2019 -
EC medical device group sheds new light on MDR, IVDR sampling codes
The Medical Device Coordination Group also issued a guidance explaining codes used to define the scope of a notified body's designation.
By Nick Paul Taylor • Dec. 12, 2019 -
Grassley, Warren press FDA to issue over-the-counter hearing aid regulations
The agency missed its estimate that the rules would come out last month, but a spokesperson said that timeline was "not intended to be a precise estimate."
By David Lim • Dec. 9, 2019 -
House bill would speed CMS coverage for breakthrough medtech
The bipartisan legislation, reintroduced on Friday, promises faster access to new medical technologies by requiring Medicare to cover devices approved through FDA's breakthrough pathway during a three-year transitional period.
By Susan Kelly • Dec. 9, 2019 -
FDA proposes alternative 510(k) criteria for MRI coils
The draft guidance would permit manufacturers to use a set of performance criteria to demonstrate substantial equivalence, instead of a direct comparison to a predicate device.
By Susan Kelly • Dec. 9, 2019 -
Impeachment clouds year-end medical device tax repeal, industry priorities
AdvaMed argues the primary obstacle to repealing the tax is not the revenue the government would no longer collect, but a crowded year-end legislative agenda and impeachment proceedings against President Donald Trump.
By David Lim • Dec. 9, 2019 -
Dive Awards
Disruption of the Year: EU MDR notified bodies shortage
The new European Union Medical Device Regulation requires more devices to undergo notified body review than ever before. But there are worries there aren't enough notified bodies to handle the workload.
By Dana Elfin • Dec. 9, 2019 -
Yujin Kim / MedTech Dive, original photo courtesy of U.S. Food and Drug Administration
Dive Awards
Regulatory Development of the Year: 510(k) changes inch along
New efforts by FDA to build out the program come years after the Institute of Medicine recommended scrapping it. More than 80% of devices are cleared through the pathway, so small changes can be meaningful to product safety.
By David Lim • Dec. 9, 2019 -
Kendall Davis/MedTech Dive
Dive Awards
The MedTech Dive Awards of 2019
From TAVR's takeoff to FDA's new approaches to premarket review, these are the industry forces that left their mark on medical technology this year.
Dec. 9, 2019 -
EPA wants more data from ethylene oxide sterilizers, strikes device-friendly tone
Administrator Andrew Wheeler said "medical device sterilization is vital to protecting public health" on release of a notice ahead of rulemaking that could impact sterilizers reliant on the carcinogenic gas.
By David Lim • Dec. 6, 2019 -
FDA grades new Medtronic SynchroMed II recall as Class I event
The voluntary move is the latest in a series of safety actions involving the implantable drug infusion pump, which was the focus of a 2015 consent decree between the company and the government.
By Nick Paul Taylor • Updated Dec. 10, 2019 -
Jacob Bell/MedTech Dive
Vicarious' surgical robot gets FDA breakthrough status
The company also announced Scott Huennekens, former CEO of Google and Johnson & Johnson's robotic surgery joint venture, joined its board of directors.
By Nick Paul Taylor • Dec. 5, 2019 -
Sens. Wyden, Booker push CMS, FTC, insurers on bias in algorithms
The lawmakers want an investigation into how use of the algorithms may lead to discrimination against marginalized populations.
By Susan Kelly • Dec. 4, 2019 -
EU Parliament panel adopts MDR delay for some Class I devices, full nod likely
One committee member called out the unusual nature of making late-in-the-game substantive regulatory changes through the corrigendum, a procedure typically meant for correcting technicalities and inconsistencies.
By Dana Elfin • Dec. 4, 2019 -
FDA commissioner nominee backs 'proactive, not passive' approach to device safety
While Stephen Hahn shed more light on his thoughts on certain medical device topics, he declined to say FDA scientific judgments of medical devices should be held to the same regulatory standards as drugs in response to a question.
By David Lim • Dec. 4, 2019 -
Hospitals sue HHS, warning price transparency rule would chill competition, crash computers
An agency spokeswoman shot back that hospitals "should be ashamed that they aren't willing to provide American patients the cost of a service before they purchase it."
By Samantha Liss • Dec. 4, 2019 -
Contract sterilizer of devices draws FDA warning over validation issues
American Contract Systems received multiple complaints about the presence of foreign matter in sealed sterilization bags, the agency said.
By Nick Paul Taylor • Dec. 4, 2019 -
FDA approves TB test from Qiagen and DiaSorin
The approval could be a win-win for both companies, bringing Qiagen's TB blood test to DiaSorin's Liaison immunoassay analyzers while expanding the testing menu for Liaison.
By Nick Paul Taylor • Dec. 2, 2019 -
With 6 months until new EU medical device rules, what's the state of play?
Preparing for the May 26, 2020, implementation of the EU's Medical Device Regulation hasn't been easy, given the lack of notified bodies designated to review devices under the more stringent standards.
By Dana Elfin • Updated Nov. 26, 2019 -
Mandatory CMS radiation oncology model goes on the backburner
Originally, the agency was eying an implementation date as early as Jan. 1, but the new regulatory agenda lists July 2022 as a target date for the bundled payment model.
By David Lim • Nov. 26, 2019
Previous
